Reference is made to the previous stock exchange announcement from SoftOx
Solutions AS (the "Company" or "SoftOx", ticker SOFTX) on 4 January 2021
regarding the Company's extraordinary general meeting resolving tranche 2 in the
previously announced private placement.
The share capital increase pertaining to tranche 2 in the private placement of
NOK 8,181.80 divided on 409,090 shares has today been registered in the
Norwegian Register of Business Enterprises (Nw: Foretaksregisteret).
Following the share capital increase, the new share capital in the Company is
NOK 174,779.80 divided into 8,738,990 shares, each with a nominal value of NOK
The new shares will be listed and tradable on Euronext Growth Oslo from issuance
in the Central Securities Depository (VPS).
For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Mobile: +47 977 59 071
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on the Oslo Stock Exchange Euronext Growth)
is a Norwegian MedTech company based in Oslo with the aim of helping to combat
major threats to human health, namely the emergence of antimicrobial resistance
(AMR), biofilm infections in chronic wounds and the spread of viruses. For more
information on SoftOx, visit www.soft-ox.com